Loading...
Loading...
Smart Money Score
Composite context from Form 4, 13F and congressional disclosures; not a forecast.
Holder clone rankings through .
Of the 14 tracked institutions holding GMED, 5 have a 3-year clone track record — 3 of them beat the S&P. Average holder's clone alpha: +1.1pt. It's a gauge of who owns the name, not just how many.
Among the 14 tracked institutional investors we monitor, GMED (GLOBUS MED INC) is held with a combined value of $2.31B across 28,160,741 shares. The largest holder is VANGUARD GROUP INC with a position worth $921.07M (0.01% of their portfolio). RENAISSANCE TECHNOLOGIES LLC opened a new position in the most recent quarter. 9 funds increased their holdings. 4 funds reduced their position.
Total Institutional Value
$2.31B
Total Shares Held
28,160,741
Institutional Holders
14
% of Shares Outstanding
21.0%
of 134.26M shares · SEC 2026-08-04
Days to Cover
5.1+24.7%
8.44M shares short · FINRA 2026-09-30
Tracked 13F institutions hold 21.0% of GMED's shares outstanding. This is a floor: 13F filings arrive on a ~45-day lag and we track only a subset of institutional filers, so true institutional ownership is higher. Shares-outstanding is the latest SEC cover-page figure (as of 2026-08-04), not a live float.
Ranked by estimated dollars moved (share change × implied price). 13F data lags up to 45 days.
| # | Fund | Value↓ | Portfolio % | Change |
|---|---|---|---|---|
| 1 | VANGUARD GROUP INC | $921.07M | 0.01% | -0.5% |
| 2 | BlackRock, Inc. | $853.84M | 0.01% | +2.9% |
| 3 | STATE STREET CORP | $293.54M | 0.01% | +3.4% |
| 4 | PRICE T ROWE ASSOCIATES INC /MD/ | $75.22M | 0.01% | +58.6% |
| 5 | FMR LLC | $60.68M | 0.00% | +27.9% |
| 6 | Grantham, Mayo, Van Otterloo & Co. LLC | $32.37M | 0.07% | +2.0% |
| 7 | Bridgewater Associates, LP | $27.81M | 0.11% | +6.5% |
| 8 | Gotham Asset Management, LLC | $22.36M | 0.05% | +89.8% |
| 9 | RENAISSANCE TECHNOLOGIES LLC | $15.56M | 0.02% | New |
| 10 | AQR CAPITAL MANAGEMENT LLC | $2.85M | 0.00% | -95.7% |
| Member | Type | Date |
|---|---|---|
| Gilbert Cisneros | Buy | Sep 3, 2026 |
| Gilbert Cisneros | Buy | Aug 19, 2026 |
| Lisa McClain | Sell | Jul 10, 2025 |
| Lisa McClain | Sell |
As of the latest SEC 13F filings, VANGUARD GROUP INC is the largest institutional holder of GMED with a position worth $921.07M, representing 0.01% of their portfolio. In total, 14 institutional investors hold GMED with a combined value of $2.31B.
In the most recent quarter, 1 fund opened a new position in GMED. Additionally, 9 increased their holdings and 4 reduced their positions.
Institutional investors hold $2.31B worth of GMED stock across 14 positions. The largest institutional holder is VANGUARD GROUP INC with $921.07M in holdings.
A 13F filing is a quarterly report required by the SEC from institutional investment managers with over $100 million in assets. It discloses their holdings in U.S. equities. For GMED, these filings reveal which major funds are accumulating or reducing positions, providing insights into institutional sentiment.
One weekly email with notable insider buys, sells and congressional disclosures. Unsubscribe anytime.
Alpha = the manager's 3-year clone return minus the S&P 500. A skilled roster is a stronger tell than a crowded one — though even skilled managers' edge doesn't reliably survive the 13F disclosure lag. Why →
| Jun 24, 2025 |
| Lisa McClain | Buy | Jun 17, 2025 |
| Josh Gottheimer | Sell | Apr 9, 2025 |
| Thomas R Tillis | Sell | Feb 13, 2015 |
Last Close
$81.41
2026-10-23
YTD
-6.7%
58% of 52-week range
